Insulin costs are rising in Iran, with insurance coverage reportedly not keeping pace. The situation is part of a broader healthcare crisis in the country, marked by shortages of essential drugs and increasing prices. The exact circumstances and potential solutions to the crisis are unclear, with various other issues also affecting Iran.